Health Care Costs among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin
May 1, 2016, 00:00
10.1016/j.jval.2016.03.102
https://www.valueinhealthjournal.com/article/S1098-3015(16)00170-4/fulltext
Title :
Health Care Costs among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00170-4&doi=10.1016/j.jval.2016.03.102
First page :
A45
Section Title :
Cardiovascular Disorders - Cost Studies
Open access? :
No
Section Order :
1433